+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Monocyte Activation Tests - Global Strategic Business Report

  • PDF Icon

    Report

  • 244 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140637
The global market for Monocyte Activation Tests is estimated at US$12.3 Million in 2023 and is projected to reach US$29.8 Million by 2030, growing at a CAGR of 13.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Monocyte Activation Test Kits segment, which is expected to reach US$16.3 Million by 2030 with a CAGR of 14.7%. The Reagents segment is also set to grow at 12.2% CAGR over the next 7 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $3.8 Million in 2023, and China, forecasted to grow at an impressive 12.8% CAGR to reach $5.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Monocyte Activation Tests Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Monocyte Activation Tests Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Monocyte Activation Tests Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Becton, Dickinson & Company, Charles River Laboratories International, Inc., Lonza Group AG, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 41 Featured):

  • Becton, Dickinson & Company
  • Charles River Laboratories International, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Microcoat Biotechnologie GmbH
  • Sanquin
  • Solvias AG
  • Thermo Fisher Scientific, Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Monocyte Activation Tests - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 2: World 7-Year Perspective for Monocyte Activation Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Monocyte Activation Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 4: World 7-Year Perspective for Monocyte Activation Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 6: World 7-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Blood Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 8: World 7-Year Perspective for Blood Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Peripheral Blood Mononuclear Cell (PBMC) Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 10: World 7-Year Perspective for Peripheral Blood Mononuclear Cell (PBMC) Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Cell Line Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 12: World 7-Year Perspective for Cell Line Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 14: World 7-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 16: World 7-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 18: World 7-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other End-Use Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 20: World 7-Year Perspective for Other End-Use Industries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 21: World Monocyte Activation Tests Market Analysis of Annual Sales in US$ for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 22: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 23: USA 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 24: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 25: USA 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 27: USA 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
CANADA
  • Table 28: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 29: Canada 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 30: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 31: Canada 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
JAPAN
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 34: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 35: Japan 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 36: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 37: Japan 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
CHINA
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 40: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 41: China 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 42: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 43: China 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 45: China 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
EUROPE
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 46: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 47: Europe 7-Year Perspective for Monocyte Activation Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 48: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 49: Europe 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 52: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 53: Europe 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
FRANCE
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 54: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 55: France 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 57: France 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 58: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 59: France 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
GERMANY
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 60: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 61: Germany 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 64: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 65: Germany 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
ITALY
  • Table 66: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 67: Italy 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 70: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 71: Italy 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
UNITED KINGDOM
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 72: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 73: UK 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 75: UK 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 76: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 77: UK 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
REST OF EUROPE
  • Table 78: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 79: Rest of Europe 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 81: Rest of Europe 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 82: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 83: Rest of Europe 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
ASIA-PACIFIC
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 85: Asia-Pacific 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 87: Asia-Pacific 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 89: Asia-Pacific 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
REST OF WORLD
  • Table 90: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 91: Rest of World 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2024 & 2030
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of World 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2024 & 2030
  • Table 94: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 95: Rest of World 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Becton, Dickinson & Company
  • Charles River Laboratories International, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Microcoat Biotechnologie GmbH
  • Sanquin
  • Solvias AG
  • Thermo Fisher Scientific, Inc.

Table Information